Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve unaudited financial results for the ...

Trastuzumab emtansine (T-DM1) demonstrates sustained improvement in invasive disease-free survival and reduced the risk for death in human epidermal growth factor receptor 2 (HER2)-positive breast ...

Ahmedabad: Zydus Lifesciences has informed in a BSE filing that the Company has appointed Vikram Shukla as a President-Parenteral Operations and designated him as the Senior Management Personnel.

Zydus Wellness Ltd share price was up by 1.60% from the previous closing price of ₹1,976.05. Who are peers of Zydus Wellness Ltd? The peers of Zydus Wellness Ltd are Hindustan Unilever Ltd ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Zydus Wellness Ltd announced that its subsidiary, Zydus Wellness Products Ltd, has received a GST demand of Rs 56.33 crore with interest and penalties from the tax authority. The demand relates to ...

Headquartered in Ahmedabad, Zydus Lifesciences is present across the pharmaceutical value chain of research, development, manufacturing, marketing, and sale of finished dosage human formulations, ...